Address: 1 Broadway, Cambridge, MA02142 (America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
Date: Saturday, June 3rd, 2023
Location: Boston Marriott Cambridge
Date: June 5-8, 2023
Location: Boston, MA
Booth: 2275-J
As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S. - West Coast)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
1. The chemical structure
ASO is single-stranded, and siRNA is double-stranded
2. Mechanism of action
• ASO either degrades target mRNA through RNase H, interferes mRNA function with steric effects or affects mRNA shearing, or acts on miRNA
• siRNA degrades mRNA mainly through RISC
3. The cellular space where the drug is exerted
Rnase H is present in both cytoplasm and nucleus, ASO can play a role in cytoplasm and nucleus, but RISC is only present in the cytoplasm, so siRNA is only present in the cytoplasm.
4. Duration of action and whether it can be amplified
• RISC can repeatedly act on the target mRNA; the effect will be longer
• The released sense strand of siRNA may be degraded and can also be used as a primer to amplify dsRNA by target mRNA as a template under the catalysis of RNA-dependent RNA polymerase. dsRNA is degraded into siRNA by Dicer and enters the RNAi cycle. Thus, the drug effect is amplified cascaded
5. Safety/Toxicity
• The toxicity of ASO is usually greater than that of siRNA, the liver and kidney toxicity of ASO is greater than that of siRNA, and the risk of thrombocytopenia of ASO (related to its structure and mechanism of action)